Section Arrow
PRFX.NASDAQ
- PRF Technologies Ltd.
Quotes are at least 15-min delayed:2026/02/17 17:36 EST
After Hours
Last
 3.22
-0.12 (-3.59%)
Bid
3.2
Ask
3.28
High 3.3411 
Low 3.22 
Volume 1.68K 
Regular Hours (Closed)
Last
 3.34
+0.38 (+12.84%)
Day High 
3.64 
Prev. Close
2.96 
1-M High
5.05 
Volume 
159.33K 
Bid
3.2
Ask
3.28
Day Low
2.85 
Open
2.9 
1-M Low
2.57 
Market Cap 
2.32M 
Currency 美元 
P/E 0.02 
%Yield -- 
10-SMA 3.1 
20-SMA 3.65 
50-SMA 4.02 
52-W High 17.95 
52-W Low 2.57 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
149.50/-25.88
Enterprise Value
2.32M
Balance Sheet
Book Value Per Share
10.78
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
HIMSHims & Hers Health16.27-0.03-0.18%30.65PE
After Hours 16.25 -0.02 -0.12%
TEVATeva Pharmaceutical Industries Limited34.41+0.43+1.27%28.08PE
After Hours 34.45 +0.04 +0.12%
HLNHaleon plc11.23+0.03+0.27%24.55PE
After Hours 11.18 -0.05 -0.45%
VTRSViatris15.74-0.03-0.19%-- 
After Hours 15.74 0 0.00%
CGCCanopy Growth Corp1.09+0.01+0.93%-- 
After Hours 1.11 +0.02 +1.83%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
PRF Technologies Ltd is a a diversified platform spanning speciality pharmaceuticals, drug-delivery technologies, and AI-driven renewable-energy analytics. PRF Technologies focuses on pharmaceutical therapies that emphasise reformulation and sustained-release drug-delivery technologies and AI-driven energy analytics. PRF-110, the Company's lead product, is based on the local anaesthetic ropivacaine and targets the postoperative pain relief market.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.